feed,title,long_url,short_url
🔐MarketWatch,FDA grants priority review to Reata's rare disease drug,http://www.marketwatch.com/news/story/fda-grants-priority-review-reatas/story.aspx?guid=%7B4B5E12BA%2D746C%2D4927%2D9673%2D47D6C2A3E4EB%7D&siteid=rss,https://on.mktw.net/3lMi29j
